Dasiglucagon for Severe Hypoglycemia: A Ready-to-Use Rescue

The clinical scenario

Severe hypoglycemia — blood sugar so low a person becomes confused, unconscious, or unable to swallow — is the most dangerous acute complication of insulin therapy. In that moment the person cannot help themselves, so someone nearby must give a rescue medicine quickly. Dasiglucagon (Zegalogue) is designed to make that rescue as fast and foolproof as possible. This use case explains its role; rescue plans are set with the care team.

Why the mechanism fits

Dasiglucagon is an engineered analog of glucagon, insulin's counter-regulatory hormone. Like glucagon, it activates the glucagon receptor on liver cells, prompting the liver to release its stored glucose (glycogenolysis) and make new glucose, rapidly raising blood sugar. Its rapid onset is exactly what a hypoglycemia rescue needs.

The standout feature: aqueous stability

Native glucagon has a practical weakness — it is unstable in water and clumps into fibrils, which is why traditional emergency kits require mixing a powder with liquid at the very moment of crisis, a fiddly step for a frightened bystander. Dasiglucagon carries amino-acid substitutions that keep it stable as a ready-to-use liquid, so it comes pre-filled in an autoinjector or syringe. There is nothing to mix: uncap and inject. Removing that step can shave crucial time and reduce errors during an emergency.

How it's given

Dasiglucagon is given as a single subcutaneous injection from a ready-to-use autoinjector or pre-filled syringe, usually by a trained family member, friend, or coworker. If there is no response, emergency help is called and repeat dosing or intravenous glucose may be needed. Once the person is alert and can swallow, they should eat to replenish liver glucose stores, and the episode should be reviewed with the care team.

Where it fits among modern rescues

Dasiglucagon is one of several ready-to-use or nasal rescues that have replaced the old mixing kits — alongside ready-to-use glucagon (Gvoke) and nasal glucagon (Baqsimi). In an emergency, the best rescue is whichever product the person and those around them are trained on and can use confidently. What matters most is that it is accessible and familiar.

A dependency to understand

Because dasiglucagon works by releasing glucose stored in the liver, it may be less effective when those stores are depleted — after prolonged fasting or starvation, or with alcohol-related lows. In those situations, or if there is no response, emergency services and intravenous glucose are essential. This limitation applies to all glucagon-based rescues.

Beyond rescue: an investigational edge

Dasiglucagon's stability in solution opens a use native glucagon cannot easily support: continuous subcutaneous infusion. This has been studied in congenital hyperinsulinism — a rare condition in which infants secrete too much insulin — and in experimental bihormonal "artificial pancreas" systems that deliver both insulin and glucagon. These are specialist or research-stage uses; the approved everyday role remains emergency rescue.

Realistic expectations

• Dasiglucagon is an emergency rescue, not a daily diabetes treatment.
• Its main advantage is ready-to-use convenience, shared by other modern glucagon products.
• It depends on liver glucose stores, so it is not universally effective.

The takeaway

Dasiglucagon takes the life-saving action of glucagon and solves its biggest practical flaw — instability in water — so a rescue can happen in seconds without mixing. For anyone at risk of severe lows, a ready-to-use rescue like this, kept accessible and used by trained bystanders, is a key part of insulin safety.

This article is educational and does not constitute medical advice. Hypoglycemia rescue plans are set with a diabetes care team.